NFKB1 and acute myeloid leukemia: In contrast, the levels of p-IκB-α and CyclinD1 were notably decreased, suggesting that MT2A can inhibit the inappropriate pathway activation of NF-κB by mediating the increased expression of IκB-α in AML-derived HL60 cells.